299 members from 50+ companies attend the Spring 2019 London and New York Network forums

Princeton, 21 June 2019:

May and June saw Navitas Life Sciences host a series of forum meetings in London and New York across our expanding portfolio of industry leading networks – pvnet, pvconnect, pvtech, labelnet, labelconnect, labeltech, and rimnet

  • 14 forum meetings across two locations – London and New York
  • 299 member participants representing 50+ life sciences companies
  • Latest industry thinking, future trends with benchmark data, and 38 member case studies resulted in rich dialogue across all of our meetings; with an 89% member satisfaction rating

Emerging hot topics across our networks include

  • The search for automated solutions continues, members shared their experiences and lessons learned. Spotlight now shifts towards wider digital initiatives notably the use of Apps, Artificial Intelligence (AI), and Analytics, as well as future directions for transformative digital initiatives e.g. blockchain
  • Regulatory intelligence continues to consume attention, driving members to share ideas on how to scan, filter, and derive insight on the ever-shifting regulatory landscape – keeping abreast of, and staying compliant with RoW and emerging markets remains a constant challenge, with members sharing strategies and solutions for innovative processes that cater for both global and local requirement
  • Amid ongoing shifts in sourcing strategies and technology investments, both vendor management and talent management move to the forefront of industry leaders’ minds. Building trusted partnership with vendors is an ongoing quest for excellence, whilst future talent strategies center on how to build new capability and release capacity to focus on value add activity
  • The patient moves to center stage...with discussions on how to bring and embed the patient voice into core PV, labeling, and regulatory processes
  • Expanded medical governance – the importance of a joined-up approach to governance across functions, processes and ever-expanding groups of internal and external stakeholders, with priority focus on governance of digital, data and patient engagement activity
  • The shift to value – remains top of mind for industry leaders, with transformation agendas and emergent capability requirements a priority strategic focus